Position in VRTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$53,684,094
+$9,303,377 QoQ
Shares Held
108,075
+8.7% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#164
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $93,187,790 across 6 Biotechnology names. VRTX ranks #1 (57.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
108,075 | $53,684,094 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,479 | $32,099,214 | |
| 3 | MRNA |
Moderna, Inc.
|
86,677 | $6,069,989 | |
| 4 | INCY |
Incyte Corp
|
7,250 | $821,860 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
3,582 | $292,183 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
13,029 | $220,450 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,684,094 | 108,075 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $44,380,717 | 99,388 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $44,441,520 | 98,027 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $31,098,565 | 79,406 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $31,247,697 | 70,188 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $31,042,054 | 64,028 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $19,403,696 | 48,184 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $7,379,889 | 15,868 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,700,132 | 16,428 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $7,086,523 | 16,953 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $8,298,521 | 20,395 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,843,275 | 22,555 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $8,419,446 | 23,925 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,280,386 | 29,455 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $10,781,601 | 37,335 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,007,223 | 41,470 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $12,009,889 | 42,620 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $14,403,455 | 55,192 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $10,378,735 | 47,262 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $8,337,046 | 45,962 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $591,178 | 2,932 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $914,571 | 4,256 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $921,489 | 3,899 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,039,933 | 18,521 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $36,565,125 | 125,952 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $41,497,290 | 174,395 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||